Tuesday, February 14, 2012

Cimzia Helps Crohn's Patients Who Don't Respond to Remicade: Study

(DG News) UPDATED 2010-03-02
According to a new study, Crohn's disease patients who do not respond to treatment with Remicade (infliximab) can experience significant improvement in their symptoms by taking Cimzia (certolizumab) every two or four weeks. Statistics show that as many as one-third of people with Crohn's disease who are treated with Remicade will stop responding to it over time, and Cimzia may offer another way for these patients to manage their disease.  Read full story >
See all Inflammatory Bowel Disease News

People who read this also read...

  • Remicade Picture
  • Kidney Disease And Remicade
  • Flu And Remicade
  • Herpes And Remicade
  • What Antidepressants Should Crohn's Patients Take?
  • Crohn's Disease Testing